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ABSTRACT:  Nimbidin, the crude bitter compound from neem has been investigated for its 
gastric anti secretory activity in rats and cats.  It exhibited significant anti – secretory activity in 
pylorus ligated rats and cats.  In lumen –  perfused rats it suppressed the basal as well as 
histamine and carbachol stimulated gastric acid output at 40 mg/kg (i.v).  However it had no 
effect on ASA – induced back – diffusion of H+ ions.  This anti secretory activity of nimbidin was 
found to be similar to that of H2 – receptor antagonists, which are reported to suppress the 
histamine induced gastric secretion in animals and man. 
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INTRODUCTION 
 
Nimbidin, the crude bitter principle from 
Azadirachta indica  A. Juss with reported 
antiulcer potential in experimental models
1 
has also exhibited multiple pharmacological 
actions in various animal models 
2-4.  In 
order to detect the mechanism of action of 
this potential antiulcer agent, the 
investigation presented in this 
communication was designed to study the 
effects of this terpenic ester on gastric acid 
secretion in various animals models. 
 
Experimental  
 
Nimbidin used in this investigation was 
isolated from neem oil of the seed kernels of 
A. indica as reported earlier
5.   Albino rats 
Holtzman strain and cats, were used as 
experimental animals.  Nimbidin was used 
as 10% (v/v) colloidal solution in alcohol 
and the control groups received only 10% 
alcohol. 
 
In pylorus – ligated rats 
 
Albino rats of either sex (150 – 200 g) fasted 
for 24h with water adlibitum were used for 
the study. A  4h  –  pylorus ligated rate 
prepartion
6,7  was used to detect the anti – 
secretory activity of nimbidin.  Test drug 
was administered in dose levels of 10,20,40 
and 80 mg / kg orally (p.o)  immediately 
after pyloric ligation.  After surgical 
procedure all the animals were kept without 
food or water and 4 hours later, killed and 
stomach dissected out.  The stomach was Pages 91 - 97 
 
opened and contents collected, centrifuged 
and volume measured.  Free and total acidity 
of gastric contents determined by titrating 
against N / 100 NaOH
8.  Pepsin 
concentration of gastric contents was 
estimated by the haemoglobin method
9 with 
modifications and expressed in mg/ml of 
gastric fluid
10.  Hexosamine concentration as 
an index of mucin content of gastric fluid 
was also determined
11  in certain 
experiments. 
 
To detect the development of tolerance on 
repeated dosing , nimbidin was administered 
orally in a daily single dose (effective dose 
from above test) of 40 mg / kg for 14 days.  
On the 14
th  day, pyloric ligation was 
performed and the final drug treatment was 
done intraduodenally (i.d) at the time of 
laparatomy.  A vehicle control group 
receiving only distilled water was also 
maintained.  Four hours after pyloric 
ligation, the rats were killed and gastric fluid 
collected and biochemical estimations 
carried out as described earlier.  The data 
were compared with that of the acute 
experiments to detect tolerance, if any. 
 
The effect of test drug on normal gastric 
secretion and on acid back –  diffusion 
caused by acetyl – salicylic acid (ASA) was 
also studied in pylorus ligated rat 
preparation.  Ten minutes after pyloric 
ligation, nimbidin (20, 40 and 80 mg / kg), 
ASA (100 mg/kg) or both was administered 
orally to the respective group of rats.  All of 
them were killed 7 h later by an over dose of 
ether, gastric contents collected and its 
volume, acidity, Na+ and K+ concentrations 
were determined
12.  
 
In stomach – lumen perfused rats 
 
Experimental performed in adult male rats 
(250 – 350 g) under urethane anesthesia as 
per the method of Lai
13.  After laparatomy, 
the stomach lumen was continuously 
perfused with 0.9% NaCl solution at 37
oC at 
a constant rate of 0.8 ml / min and every 10 
min effluent collected was titrated against N 
/ 100 NaOH with phenolphthalein as 
indicator using micropipette.  The adic 
concentration was expressed in µEq / 10 
min
14.  Nimbidin was administered i.v. via 
tail vein in doses of 20 and 40 mg / kg and 
noted its influence on basal secretion.   
Gastric acid secretion was stimulated using 
histamine acid phosphate (250 –  500 µg / 
100g) or carbachol (5 µg / kg) intravenously 
and influence of drug on these secretagogues 
was also determined.  Cimetidine in doses of 
100 and 200 µmol/kg (i.v.) was used as 
reference drug for comparing the effect on 
basal gastric secretion in rats. 
 
In pylorus – ligated anaesthetized cats 
 
Twenty four hour fasted male cats were 
anaesthetized with pentobarbitone sodium 
(35 mg / kg i.p) and after laparatomy the 
pyloric end of stomach was ligated.  The 
stomach was then washed with warm saline 
with a stomach tube  passed through the 
oesophagus, 30 min later, 40 ml of 70% 
ethanol was given through the stomach tube.  
The zero hour sample was collected after 15 
min and the test drug or 10% alcohol 
(control) was injected i.v.  After 5 min 
histamine acid phosphate ( 2µg/kg/min) was 
infused through the femoral vein by a slow 
injector.  Samples of gastric contents (3 ml) 
were aspirated every 30 min for the next 180 
min and replaced by an equivalen amount of 
7% ethanol.  The samples were filtered 
through cotton wool before determinin the 
free and total acidity using O,1 N NaOH
15.  
Nimbidin was given i.v. in dose levels of 20 
and 40 mg/kg and 4 cats were used at each 
dose level. 
 
Students ‘t’ test was employed for statistical 
analysis: Pages 91 - 97 
 
 
RESULTS AND DISCUSSION 
 
In all the dose  levels tested nimbidin oral 
administration showed a decreased gastric 
secretory volume in 4 h –  pylorus ligated 
rats, but without any dose –  response 
relationship.  At 40 mg/kg there was a 
significant fall (p<0.01) in gastric secretion 
but without any significant reduction in 
acidity, peptic activity or hexosamine 
content of gastric fluid.  However at 20 
mg/kg there was a significant (p<0.01) fall 
in peptic activity (Table 1). 
 
Chronic oral dosing for 14 days did not 
show any significant reduction in gastric 
secretion or acidity but there was significant 
9p<0.01) suppression of peptic activity of 
gastric fluid with 40 mg / kg dose.  (Table 
2). 
 
Nimbidin in all the three dose levels tested 
did not prevent the back – diffusion of acid 
(H+) and apparent efflux  of Na+ and K+ 
associated with ASa treatment (Table 3). 
 
In stomach lumen perfused rats, nimbidin in 
20 and 40 mg/kg (i.v.) exhibited marked 
suppression of unstimulated gastric acid 
output (total).  In 40 mg/kg treated group, 
the mean basal acid secretion of gastric 
effluent fraction was 23.8 ± 1.40 µEq / 10 
min, whereas at the end of 160 min the acid 
secretion was only 16.3 ± 0.20 µEq / 10 min 
(Fig 1a and b).  Cimetidine in 200 µmo 1 / 
kg shoed significant suppression of basal 
acid secretion with a steady fall to 13.8 ± 0.3 
µEq / 10 min at the end of 160 min (Fig 2a 
and b), Nimbidin (40 mg/kg) treatment 
exhibited a partial suppression of the 
stimulatory effect of the second histamine 
injection (5 mg/kg) on gastric secretion in 
these rats (Fig 1-c).  The peak acid output 
after the second histamine injection was 
26.3 ± 4.0 µEq / 10 min,  whereas during 
first injection before nimbidin was 34 ± 10 
µEq / 10 min.  Similarly the stimulatory 
effect of carbachol (5 µg/kg) was also 
partially blocked by nimbidin (40 mg/kg) in 
anaesthetised rats (Fig. 1d).  The carbachol 
induced peak acid out after first injection 
was 26 ± 2.0 µEq / 10 min and after 
nimbidin the peak output of gastric acid was 
reduced to 20 ± 2.0 µEq / 10 min. 
 
 
TABLE I 
 
Effect of oral administration of nimbidin on gastric secretion in pylorus – ligated rats. 
 
  Treatment (mg/kg)  No. of 
animals 
Gastric secretion (mean ± S. E.) 
Volume 
(ml/100g/4h) 
Acidity (mEq/L)  Pepsin Conc. 
(mg/ml)  Free  Total 
a. 
 
 
b 
 
 
c 
 
 
Vehicle –  
Control 
 
Nimbidin –  
10 
 
Nimbidin –  
20 
 
12 
 
 
10 
 
 
12 
 
 
3.61 ± 0.32 
 
 
3.31 ± 0.28 
 
 
2.65 ± 0.37 
 
 
67.66 ±  
7.45 
 
68.20 ± 
4.56 
 
49.25 ± 
7.89 
 
124.75 ±  
9.25 
 
112.50 ± 
3.70 
 
105.25 ± 
6.44 
 
159.66 ±  
5.93 
 
145.40 ± 
5.49 
 
132.33 ± ** 
5.74 
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d 
 
 
e 
Nimbidin – 
40 
 
Nimbidin – 
80 
10 
 
 
10 
2.23 ± 0.21** 
 
 
3.48 ± 0.40 
50.90 ± 
7.46 
 
81.40 ± 
4.65 
 
110.60 ± 
12.06 
 
125.90 ± 
2.42 
141.50 ±  
7.08 
 
148.40 ± 
6.48 
 
  P value  - ** < 0.01 
 
TABLE II 
   
Effect of chronic oral administration (14 days) of nimbidin on gastric secretion in rats. 
 
  Treatment (mg/kg)  No. of 
animals 
Gastric secretion (mean ± S. E.) 
Volume 
(ml/100g/4h) 
Acidity (mEq/L)  Pepsin Conc. 
(mg/ml)  Free  Total 
a. 
 
 
b 
 
 
c 
 
 
d 
 
Control – 
D. Water 
 
Vehicle –  
Control 10% alcohol 
 
Nimbidin –  
40 
 
Nimbidin –  
80 
8 
 
 
8 
 
 
12 
 
 
8 
4.39 ± 0.50 
 
 
4.56 ± 0.80 
 
 
3.55 ± 0.41 
 
 
3.42 ± 0.64 
81.87 ± 
5.80 
 
80.50 ± 
5.98 
 
81.75 ± 
6.80 
 
85.00 ± 
7.63 
129.75 ± 
5.08 
 
130.75 ± 
5.33 
 
139.16 ± 
3.42 
 
130.00 ± 
7.63 
258.74 ± 
16.28 
 
230.16 ± 
17.03 
 
177.41 ± ** 
3.65 
 
228.80 ± 
2.82 
 
P value - ** < 0.01 
 
TABLE III 
   
Effect of nimbidin, asaa and nimbdin + asa on gastric secretion in pylorus – ligated  
 
  Treatment  Dose 
mg/kg 
No. of 
rats 
Gastric contents 
Volume 
(ml/100g/7h) 
H+  Na+ 
(mEq/L) 
K+ 
a. 
 
 
b. 
 
 
c. 
 
 
 
Control  
(1 % CMC) 
 
Vehicle Control 
(10 % alcohol) 
 
Nimbidin 
 
 
 
- 
 
 
- 
 
 
20 
 
 
 
10 
 
 
10 
 
 
10 
 
 
 
6.6  ± 
0.62 
 
6.8  ± 
0.41 
 
5.9  ± 
0.72 
 
 
94.1 ± 
3.92 
 
92.7 ± 
4.23 
 
105.3 ± 
8.65 
 
 
77.4 ± 
5.57 
 
75.9 ± 
5.44 
 
75.8 ± 
5.44 
 
 
7.1 ± 
0.52 
 
7.3 ± 
0.56 
 
6.3 ± 
0.87 
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d. 
 
 
e. 
 
 
f. 
 
 
g. 
 
 
h. 
 
 
i. 
Nimbidin 
 
 
Nimbidin 
 
 
ASA 
 
 
Nimbidin + 
ASA 
 
Nimbidin + 
ASA 
 
Nimbidin + 
ASA 
 
40 
 
 
80 
 
 
100 
 
 
20 + 
100 
 
40 + 
100 
 
80 + 
100 
10 
 
 
8 
 
 
10 
 
 
10 
 
 
10 
 
 
10 
 
5.3  ± 
0.57 
 
6.2 ± 
0.06 
 
5.4  ± 
0.38 
 
6.6 ± 
0.82 
 
6.4 ± 
0.57 
 
6.3 ± 
0.57 
 
92.5 ± 
2.75 
 
86.5 ± 
2.75 
 
80.2 ± 
3.98 
 
79.0 ± 
5.65 
 
77.7 ± 
5.04 
 
78.5 ± 
4.34 
88.4 ± 
6.47 
 
62.5 ± 
8.05 
 
83.6 ± 
6.12 
 
77.8 ± 
5.54 
 
76.9 ± 
3.59 
 
62.5 ± 
12.68 
7.8 ± 
0.81 
 
9.1 ± 
1.25 
 
8.4 ± 
0.61 
 
9.1 ± 
0.84 
 
7.7 ± 
0.74 
 
9.3 ± 
0.24 
 
P Values – H + : b:e N. S., b : f < 0.05, b : g N. S. 
        b : h < 0.05, b : I ( 0.05, f : h N. S. 
Volume   - b : c N. S., b : d < 0.05, b : f < 0.05 
 
In anaesthetized cats, nimbidin 40 mg/kg 
(i.v.) showed an apparent reduction in both 
free and total acidity of gastric effluents 
under constant histamine infusion.  At 120 
min of drug administration there was a 
significant (p <  0.05)  reduction  in free 
acidity.  However test drug in 20 mg / kg 
dose did not show any effect on histamine 
induced gastric acidity but it rather increased 
the acidity.  But the gastric acidity induced 
by histamine was neither completely 
blocked nor brought back to basal level 
during the period of observation (Table 4). 
 
Histamine H2 – receptor antagonists inhibit 
not only gastric secretion elicited by injected 
histamine, but also basal secretion and that 
elicited by various physiological stimuli
16.  
Even though nimbidin did not exhibit and 
H2 – receptor blocking activity in rat uterus 
(in  –  vitro study) (unpublished data), in 
stomach lumen perfused rat preparation, test 
drug was found to inhibit basal acid 
secretion in both dose levels and at 40mg/ 
kg it markedly reduced the histamine and 
carbachol stimulated acid output.  Similarly, 
nimbidin in 40 mg/kg dose level 
significantly reduced the free acidity in 
anaesthetized cats receiving a constant i.v. 
infusion of histamine.  Cimetidine, the 
potent H2 – receptor antagonist also caused 
inhibition of basal as well as histamine 
evoked gastric secretion in rats and dogs
17 
and in man a similar dose – dependent effect 
is seen after oral or parenteral 
administration
18.  Hence the anti – secretory 
effect of nimbidin in cats and rats, could be 
attributable to its pasted H2 –  receptor 
antagonism.  Thus the anti – ulcer potential 
of this compound might be due to its anti 
secretory property contributed by its H2 – 
receptor antagonism as well as weak anti 
cholinergic and ganglion blocking properties 
already reported. 
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TABLE IV 
 
Effect of nimbidin on histamine ( 2 µg/kg/min) induced gastric acidity in anesthetized cats 
 
Treatment 
(mg/kg i.v.) 
0 min  30 min  40 min  90 min  120 min  150 min  180 min 
FA  TA  FA  TA  FA  TA  FA  TA  FA  TA  FA  TA  FA  TA 
(Mean ± S. E) 
i. 
 
 
 
 
ii. 
 
 
 
iii. 
Vehicle  – 
control 
(10% Al.) 
(4) 
 
Nimbidin – 
20 
(4) 
 
Nimbidin – 
40 
(4) 
0 
 
 
 
 
0 
 
 
 
0.8 ± 
0.2 
7.5 ± 
2.3 
 
 
 
8.0 ± 
4.2 
 
 
6.2 ± 
0.1 
 
4.0 ± 
2.0 
 
 
 
6.6 ± 
2.7 
 
 
1.9 ± 
1.5 
11.4 ± 
3.9 
 
 
 
17.3 ± 
2.7 
 
 
6.8 ± 
2.8 
 
 
8.7 ± 
3.5 
 
 
 
12.6 ± 
6.2 
 
 
5.1 ± 
3.1 
 
 
19.6 ± 
9.3 
 
 
 
22.8 ± 
6.4 
 
 
10.4 ± 
4.5 
 
 
15.5 ± 
4.1 
 
 
 
22.4 ± 
11.3 
 
 
7.6 ± 
3.5 
 
 
23.7 ± 
6.2 
 
 
 
37.1 ± 
17.8 
 
 
14.4 ± 
5.9 
25.3 ± 
4.1 
 
 
 
35.4 ± 
17.4 
 
 
11.5 ±* 
4.1 
 
 
33.4 ± 
5.8 
 
 
 
58.2 ± 
28.2 
 
 
22.5 ± 
6.2 
 
 
24.4 ± 
6.5 
 
 
 
36.4 ± 
18.6 
 
 
14.7 ±* 
0.1 
 
 
35.7 ± 
10.3 
 
 
 
50.9 ± 
22.8 
 
 
25.1 ± 
5.4 
 
 
40.5 ± 
7.5 
 
 
 
39.7 ± 
0.1 
 
 
18.5 ±* 
5.4 
 
51.6 ± 
9.5 
 
 
 
54.3 ± 
24.1 
 
 
32.8 ± 
0.1 
 
 
   
P value - * < 0.05.  Figures in the parenthesis indicate number of animals in the group. 
FA  - Free acidity, TA – Total acidity. 
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